Verastem Inc (VSTM)

Aug 10, 2025

Verastem (VSTM.O) Surges 19.9% on KDJ Golden Cross and Mysterious Order Flow - AInvest

Aug 10, 2025

Aug 10, 2025

Verastem Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 10, 2025

Aug 09, 2025

Verastem (VSTM.O) Surges 19.9%: What’s Behind the Sharp Intraday Move? - AInvest

Aug 09, 2025

Aug 09, 2025

Using Python tools to backtest Verastem Inc. strategiesAI Trend Detection for Entry Timing - Newser

Aug 09, 2025

Aug 09, 2025

What makes Verastem Inc. stock price move sharplyMassive ROI Stock Selections - thegnnews.com

Aug 09, 2025

Aug 08, 2025

Verastem's (VSTM) Breakthrough in KRAS-Driven Cancers and Commercialization Momentum - AInvest

Aug 08, 2025

Aug 08, 2025

Transcript : Verastem, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 08, 2025

Aug 08, 2025

Verastem stock climbs on Q2 beat (VSTM:NASDAQ) - Seeking Alpha

Aug 08, 2025

Aug 08, 2025

Verastem’s Promising Phase 3 Study in Ovarian Cancer: A Potential Game-Changer? - TipRanks

Aug 08, 2025

Aug 08, 2025

RBC Raises Price Target on Verastem to $13 From $12, Keeps Outperform, Speculative Risk - MarketScreener

Aug 08, 2025

Aug 08, 2025

Verastem Inc files for mixed shelf offering of up to $300 millionSEC filing - MarketScreener

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Verastem Q2 2025 sees revenue growth and FDA approval - Investing.com

Aug 08, 2025

Aug 08, 2025

Verastem’s Promising Market Expansion and Financial Health Drive Buy Rating - TipRanks

Aug 08, 2025

Aug 08, 2025

Verastem: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025

Aug 08, 2025

Verastem Q2 2025 Earnings Call Transcript - MarketBeat

Aug 08, 2025

Aug 08, 2025

Verastem Inc (VSTM) Q2 2025 Earnings Call Highlights: FDA Approval and Strong Launch Drive ... By GuruFocus - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Verastem Oncology’s Q2 2025 Financial and Business Highlights - TipRanks

Aug 08, 2025

Aug 08, 2025

Verastem Inc (VSTM) Q2 2025 Earnings Call Highlights: FDA Approval and Strong Launch Drive Positive Momentum - GuruFocus

Aug 08, 2025

Aug 08, 2025

Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates - BioSpace

Aug 08, 2025

Aug 07, 2025

Verastem 2025 Q2 Earnings Deepened Losses Amid Product Launch - AInvest

Aug 07, 2025

Aug 07, 2025

Verastem Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Custom strategy builders for tracking Verastem Inc.Free Short Term Buy List With Stop Protection - Newser

Aug 07, 2025

Aug 07, 2025

Verastem Oncology Gambles On Cancer Drug Launch Despite Deepening Losses - Finimize

Aug 07, 2025

Aug 07, 2025

Verastem (VSTM) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 07, 2025

Aug 07, 2025

Verastem's Q2 2025 Earnings and Pipeline Progress: A Deep Dive into R&D Momentum and Long-Term Value Creation - AInvest

Aug 07, 2025

Aug 07, 2025

Biopharma firm Verastem Oncology Q2 net loss widens - MarketScreener

Aug 07, 2025

Aug 07, 2025

Verastem reports Q2 EPS (39c) vs. (31c) last year - TipRanks

Aug 07, 2025

Aug 07, 2025

Verastem CEO Paterson sells $7,738 in shares By Investing.com - Investing.com South Africa

Aug 07, 2025

Aug 07, 2025

Verastem CEO Paterson sells $7,738 in shares - Investing.com

Aug 07, 2025

Aug 07, 2025

Will Verastem Inc. continue its uptrendIntelligent Trade Forecast With AI Analytics - Newser

Aug 07, 2025

Aug 06, 2025

Intrinsic Value of Verastem Inc. Stock: Is It Undervalued or OvervaluedTechnical Trend Forecast for Investors - Newser

Aug 06, 2025

Aug 05, 2025

Best data tools to analyze Verastem Inc. stockTrading Watchlist with Real Time Filters - Newser

Aug 05, 2025

Aug 05, 2025

Visual trend scoring systems applied to Verastem Inc.Free Pattern Alert With ROI Driven Strategy - Newser

Aug 05, 2025

Aug 05, 2025

Leading vs lagging indicators on Verastem Inc. performanceFree News Based Entry Opportunity Alerts - Newser

Aug 05, 2025

Aug 05, 2025

Verastem VSTM Q2 2025 Earnings Preview Upside Potential on Strong Revenue Growth - AInvest

Aug 05, 2025

Aug 04, 2025

Jefferies Financial Group Inc. Makes New $1.63 Million Investment in Verastem, Inc. (NASDAQ:VSTM) - Defense World

Aug 04, 2025

Aug 03, 2025

Does Verastem Inc. stock perform well during market downturnsUnlock powerful market trend analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What markets is Verastem Inc. expanding into Is TROO stock a good long term investment option - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Verastem Inc. company’s balance sheetHigh-yield market plays - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Verastem Inc. stock overvalued or undervaluedInvest confidently with advanced analysis tools - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Verastem Inc. compare to its industry peersAchieve breakthrough gains with expert advice - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Verastem Inc. stock in 2025Maximize gains with expert analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is Verastem Inc. company’s growth strategyUnstoppable profit momentum - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Verastem Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Verastem Inc. stock priceOutperformance with explosive growth - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What analysts say about Verastem Inc. stockFree Consultation - Jammu Links News

Aug 02, 2025

Aug 02, 2025

When is Verastem Inc. stock expected to show significant growthMarket-crushing stock picks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Verastem, Inc. (NASDAQ:VSTM) Sees Large Growth in Short Interest - Defense World

Aug 02, 2025

Aug 01, 2025

Why Verastem Inc. stock attracts strong analyst attentionBuy Signal Based on Chart Analysis Confirmed - beatles.ru

Aug 01, 2025

Aug 01, 2025

Is Verastem Inc. reversing from oversold territoryWeekly Signal Report with Trend Summary - Newser

Aug 01, 2025